Screener
Haemonetics
HAEHaemonetics is a global medical technology company that provides innovative solutions for blood and plasma collection, surgical blood management, and interventional procedures.
Earnings
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$345.0M
EPS estimate$1.30
Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Haemonetics is a global medical technology company that provides innovative solutions for blood and plasma collection, surgical blood management, and interventional procedures. The company's core value proposition centers on improving healthcare efficiency and patient outcomes through automated collection systems, specialized surgical devices, and integrated information technology platforms.
Competitive position
A global leader in automated plasma collection and advanced viscoelastic testing, maintaining a strong market position in vascular closure and blood management technologies.
GeographiesNorth America, Europe, Asia Pacific, Global
Customer segmentsBiopharmaceutical manufacturers, Hospitals, Blood banks, Surgical centers
Business modelManufacturing, Hardware-as-a-Service, Software-as-a-Service, Consumables-driven revenue
SuppliersContract manufacturers for capital equipment, Raw material suppliers (plastics and components), Sterilization service providers
CustomersBiopharmaceutical companies (fractionators), Hospital systems, Blood collection organizations, Group purchasing organizations
CountryUnited States of America
Listed1991
Employees3.7K
CEOChristopher A. Simon
SectorHealthcare
IndustryMedical - Instruments & Supplies
Websitehaemonetics.com
FilingsSEC EDGAR
FAQ
- What is Haemonetics's market cap?
- Haemonetics (HAE) has a market capitalization of $4.8B and trades on NYSE.
- What is Haemonetics's revenue and profitability?
- Haemonetics generated $1.4B in trailing twelve-month revenue with net income of $150.5M, representing a net margin of 13.3%. Gross margin stands at 59.0%, with free cash flow of $291.2M. The latest reported period is Q1 2027.
- Who are Haemonetics's competitors?
- Haemonetics's key competitors include Teleflex, Cytosorbents Corp., Abbott Laboratories, and others. These companies compete in similar markets and product categories.
- Who does Haemonetics partner with?
- Haemonetics's notable partners include American Red Cross.
- What subsidiaries does Haemonetics have?
- Haemonetics's subsidiaries include OpSens Inc., Attune Medical, Vivasure Medical Limited.
- Where is Haemonetics headquartered?
- Haemonetics is headquartered in United States of America and employs approximately 3,657 people. It has been publicly traded since 1991.
